Inogen (INGN)
(Delayed Data from NSDQ)
$8.69 USD
-0.04 (-0.46%)
Updated Nov 1, 2024 03:59 PM ET
After-Market: $8.69 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth A Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$8.69 USD
-0.04 (-0.46%)
Updated Nov 1, 2024 03:59 PM ET
After-Market: $8.69 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth A Momentum A VGM
Zacks News
Medtronic's Positive 2-Year SURTAVI Data Boosts Corevalve
by Zacks Equity Research
Medtronic plc (MDT) has released the first-ever clinical data from the Surgical Replacement and Transcatheter Aortic Valve Implantation (SURTAVI) Trial.
Abbott Laboratories' MitraClip Outcome Positive for DMR
by Zacks Equity Research
Abbott Laboratories (ABT) recently presented one-year positive outcomes from the study of the MitraClip system in transcatheter mitral valve repair (TMVR) procedures in the U.S.
Fresenius (FMS) to Jointly Develop Acumen with Epic Systems
by Zacks Equity Research
Fresenius Medical Care AG & Co. KGAA (FMS) announced that it would jointly develop Acumen 2.0 with Epic Systems Corporation.
Thermo Fisher Poised on Innovation, Global Growth Amid Woes
by Zacks Equity Research
On Mar 17, 2017, we issued an updated research report on Thermo Fisher Scientific Inc. (TMO).
PharMerica Takes Over CareMed, Expands in Specialty Pharmacy
by Zacks Equity Research
PharMerica Corporation (PMC) recently announced the acquisition of CareMed Specialty Pharmacy, a leading provider of specialty pharmacy services. However, all the other terms of the deal have been kept under wraps.
Air Methods (AIRM) Opens New Training Facility in Colorado
by Zacks Equity Research
Air Methods Corporation (AIRM) announced the opening of new FlightSafety Learning Center in Denver, CO.
CVS Health Launches Reduced Rx for Affordable Medication
by Zacks Equity Research
CVS Health Corporation (CVS), a leading name in pharmacy benefit and retail pharmacy, recently announced the launch of a prescription savings program-Reduced Rx.
STERIS Continues to Trade Below Industry on Dull Outlook
by Zacks Equity Research
On Mar 16, we issued an updated research report on Ohio-based STERIS plc (STE).
3 Medical Device Stocks to Brave Policy Uncertainty
by Zacks Equity Research
We believe stocks with strong fundamentals that also have a significant share of their business overseas may well brace themselves in the on-going conundrum. They will make lucrative additions to your portfolio.
Integra (IART) Titan Reverse Launch Expands Extremity Line
by Zacks Equity Research
Integra LifeSciences (IART) recently broadened its extremity product line with the launch of its Titan Press-Fit Reverse Shoulder for Fracture.
Medtronic's Melody TPV Wins FDA for Less-Invasive Treatment
by Zacks Equity Research
Medtronic plc (MDT) recently won FDA approval for Melody Transcatheter Pulmonary Valve for implantation in patients whose surgical bioprosthetic pulmonary heart valves have failed.
Align Technology Hits a 52-Week High on Solid Prospects
by Zacks Equity Research
Share price of San Jose, CA-based Align Technology, Inc. (ALGN) reached a new 52-week high of $110.87 on Mar 15, eventually closing a bit lower at $110.31.
Zacks.com featured highlights: Potbelly, Inogen, U.S. Silica Holdings, NextEra Energy Partners and Diamondback Energy
by Zacks Equity Research
Zacks.com featured highlights: Potbelly, Inogen, U.S. Silica Holdings, NextEra Energy Partners and Diamondback Energy
Your Guide to the Stock Winners & Losers of Trump's Obamacare Replacement Bill
by Madeleine Johnson
Whether you think it???s "Obamacare Lite," "Obamacare 2.0," "dead on arrival" like Rand Paul, or you actually like the bill, the American Healthcare Act (AHCA) has certainly made an impact on the entire healthcare industry since its announcement. Who are the stock winners and losers so far? And who will be affected if it's passed?
Patterson (PDCO) Rewards Shareholders with 8% Dividend Hike
by Zacks Equity Research
Patterson Companies Inc. (PDCO) recently hiked its quarterly dividend by 8% to 26 cents per share from 24 cents.
Air Methods (AIRM) Set to be Acquired for $2.5 Billion
by Zacks Equity Research
Air Methods Corporation (AIRM) announced that it is set to be acquired by New York-based private equity firm American Securities LLC for $2.5 billion.
Medtronic's New Reveal LINQ ICM Gets FDA 510(k) Clearance
by Zacks Equity Research
Medical device major, Medtronic plc (MDT) recently received the U.S. FDA 510(k) clearance for its Reveal LINQ Insertable Cardiac Monitor (ICM) with TruRhythm Detection.
AngioDynamics Microwave Tissue Ablation System Now CE Marked
by Zacks Equity Research
AngioDynamics Inc. (ANGO), a leading provider of minimally invasive medical devices, recently announced the receipt of CE mark for Solero Microwave Tissue Ablation (MTA) System.
Stryker Launches MAKO Robotic-Arm for Knee Anthroplasty
by Zacks Equity Research
Stryker Corporation (SYK) recently announced the commercial launch of a robotic-arm assisted total knee arthroplasty application based on its flagship MAKO System.
IDEXX (IDXX) Poised on Strong Fundamentals, Innovations
by Zacks Equity Research
On Mar 14, we issued an updated research report on IDEXX Laboratories, Inc. (IDXX).
Ensign Group Signs Lease Agreement with Mainstreet Health
by Zacks Equity Research
The Ensign Group, Inc. (ENSG) recently signed definitive agreements to simultaneously sell and lease two skilled nursing facilities and one assisted living community to Mainstreet Health Investments Inc.
Is it Wise to Hold Universal Health (UHS) in Your Portfolio?
by Zacks Equity Research
Headquartered in King of Prussia, PA, Universal Health Services Inc. (UHS) stock has gained 12.8% year to date, significantly higher than the increase of 7.6% witnessed by the Zacks categorized medical sector.
Zacks.com featured highlights: Children's Place, Broadcom, Stoneridge, Inogen and Customers Bancorp
by Zacks Equity Research
Zacks.com featured highlights: Children's Place, Broadcom, Stoneridge, Inogen and Customers Bancorp
5 Top-Ranked Stocks to Tap Earnings Beat Potential
by Zacks Equity Research
Forget earnings growth, bet on these top-ranked stocks to cash in on earnings beat.
Neovasc (NVCN) Catches Eye: Stock Adds 27.1% in Session
by Zacks Equity Research
Neovasc Inc. (NVCN) moved big last session, as its shares jumped a little over 27% on the day.